MATES, SHARON,FIENBERG, ALLEN A.,WENNOGLE, LAWRENCE P.
申请号：
EP09755263
公开号：
EP2320731A4
申请日:
2009.05.27
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-HT 2A , SERT and/or dopamine D 2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinsons disease or any combinations.
